FDA nom­i­na­tion in hand, Got­tlieb pre­pares to dis­en­tan­gle him­self from a long list of bio­phar­ma jobs and in­vest­ments

Steve Burd (R), pres­i­dent and CEO, Safe­way, Inc. and Scott Got­tlieb (L), res­i­dent fel­low at Amer­i­can En­ter­prise In­sti­tute par­tic­i­pate in a Sen­ate Health, Ed­u­ca­tion, La­bor and Pen­sions Com­mit­tee hear­ing on Capi­tol Hill, June 11, 2009 in Wash­ing­ton, DC. (Cred­it: Mark Wil­son/Get­ty Im­ages)

Scott Got­tlieb wasn’t idle dur­ing the eight years of the Oba­ma ad­min­is­tra­tion. With De­moc­rats in the White House and Re­pub­li­cans out, the for­mer agency of­fi­cial turned to a busy ca­reer work­ing with quite a range of bio­phar­ma in­vestors and com­pa­nies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER